Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in San Francisco, CA
NPI: 1457372823Primary Practice Location
Sutter Pacific Medical Foundation
1100 Van Ness Ave, San Francisco, CA
Primary Employer
Sutter Pacific Medical Foundation
sutterhealth.org
HQ Phone
Get M.D. Jonathan's Phone Numberphone_androidMobile
Get M.D. Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1995 - 2027
TX State Medical License
1993 - 1995
WA State Medical License
1989 - 1994
American Board of Psychiatry and Neurology
Neurology
Tulane School of Medicine
medicine.tulane.edu
Medical School
Until 1988
University of Washington
Residency • Neurology
1989 - 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 138 | 236 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 61 | 61 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 51 | 58 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 39 | 40 |
| 5 | 97161Evaluation of physical therapy, typically 20 minutes | 21 | 27 |
Leprous neuropathy: an American perspective.
Authors: Sharon Nations, Carolyn Lyde
Journal: Semin Neurol
Seeking a measure of clinically meaningful change in ALS
Authors: Ericka Greene, Robert Miller, Stanley Appel
Journal: Amyotroph Lateral Scler Frontotemporal Degener
Publication Date: 2014-08-15
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.
Authors: Robert Miller, Jonathan Katz, Gilbert Block, Edward Kasarskis
Journal: Amyotroph Lateral Scler Frontotemporal Degener
Publication Date: 2014-09-05
Lead Sponsor: University of Miami
Collaborators: National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), National Center for Advancing Translational Sciences (NCATS), Muscular Dystrophy Association
Lead Sponsor: Richard Barohn, MD
Intervention / Treatment: DRUG: Placebo, DRUG: Rasagiline
Lead Sponsor: Barrow Neurological Institute
Collaborators: ALS Association, Muscular Dystrophy Association, Synapse Biomedical
Intervention / Treatment: DEVICE: NeuRx® Diaphragm Pacing System™ (DPS)
